Literature DB >> 11412103

NMR analysis of structure and dynamics of the cytosolic tails of integrin alpha IIb beta 3 in aqueous solution.

T S Ulmer1, B Yaspan, M H Ginsberg, I D Campbell.   

Abstract

The structural and dynamic properties of the cytosolic tails of the adhesion receptor integrin alphaIIbbeta3, fused to a coiled-coil construct via (Gly)(3) linkers, were studied in aqueous solution by nuclear magnetic resonance (NMR) spectroscopy. Both tails were largely flexible and unstructured, although, in the beta3 tail, residues Arg(724)-Ala(735) have a propensity to form a helical structure and residues Asn(744)-Tyr(747) (NPLY) have a propensity to adopt reverse-turn conformations. The mutation beta3(Y747A) disrupted this reverse-turn tendency and markedly reduced the affinity of the head domain of the cytoskeletal protein, talin for the beta3 tail. Omission of the (Gly)(3) linker connecting the coiled-coiled helices and the integrin tails lead to helix propagation into the beta3 tail extending up to eight residues. A variety of different tail constructs were made and studied to reveal tail-tail interactions, but surprisingly no significant interactions between both tails could be detected within the context of our constructs. These results provide structural insight into a highly conserved beta tail motif (NPXY/F) required for integrin signaling and highlight a second transiently structured region (residues Arg(724)-Ala(735)), which might also be of functional significance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11412103     DOI: 10.1021/bi010338l

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  44 in total

1.  Solution structures of the cytoplasmic tail complex from platelet integrin alpha IIb- and beta 3-subunits.

Authors:  Aalim M Weljie; Peter M Hwang; Hans J Vogel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

2.  Oligomerization of the integrin alphaIIbbeta3: roles of the transmembrane and cytoplasmic domains.

Authors:  R Li; C R Babu; J D Lear; A J Wand; J S Bennett; W F DeGrado
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

3.  Integrin beta cytoplasmic domain interactions with phosphotyrosine-binding domains: a structural prototype for diversity in integrin signaling.

Authors:  David A Calderwood; Yosuke Fujioka; Jose M de Pereda; Begoña García-Alvarez; Tetsuya Nakamoto; Ben Margolis; C Jane McGlade; Robert C Liddington; Mark H Ginsberg
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-26       Impact factor: 11.205

4.  Three-dimensional model of the human platelet integrin alpha IIbbeta 3 based on electron cryomicroscopy and x-ray crystallography.

Authors:  Brian D Adair; Mark Yeager
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-18       Impact factor: 11.205

5.  Transmembrane signal transduction of the alpha(IIb)beta(3) integrin.

Authors:  Kay E Gottschalk; Paul D Adams; Axel T Brunger; Horst Kessler
Journal:  Protein Sci       Date:  2002-07       Impact factor: 6.725

6.  Suppression of integrin activation by the membrane-distal sequence of the integrin alphaIIb cytoplasmic tail.

Authors:  Jun Yamanouchi; Takaaki Hato; Tatsushiro Tamura; Shigeru Fujita
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

7.  Subcellular localization of talin is regulated by inter-domain interactions.

Authors:  Asoka Banno; Benjamin T Goult; HoSup Lee; Neil Bate; David R Critchley; Mark H Ginsberg
Journal:  J Biol Chem       Date:  2012-02-18       Impact factor: 5.157

Review 8.  Regulation of platelet beta 3 integrins.

Authors:  Joel S Bennett; David T Moore
Journal:  Haematologica       Date:  2010-07       Impact factor: 9.941

9.  Tyrosine phosphorylation as a conformational switch: a case study of integrin β3 cytoplasmic tail.

Authors:  Lalit Deshmukh; Nahum Meller; Nathan Alder; Tatiana Byzova; Olga Vinogradova
Journal:  J Biol Chem       Date:  2011-09-28       Impact factor: 5.157

Review 10.  Integrin αIIbβ3: from discovery to efficacious therapeutic target.

Authors:  Kamila Bledzka; Susan S Smyth; Edward F Plow
Journal:  Circ Res       Date:  2013-04-12       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.